000			01924 a2200541 4500
005			20250515031137.0
264		0	_c20060718
008			200607s 0 0 eng d
022			_a1524-4628
024	7		_a10.1161/01.STR.0000227191.01792.e3 _2doi
040			_aNLM _beng _cNLM
100	1		_aYamaguchi, Takenori
245	0	0	_aAlteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). _h[electronic resource]
260			_bStroke _cJul 2006
300			_a1810-5 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBrain Ischemia _xdrug therapy
650	0	4	_aCerebral Hemorrhage _xchemically induced
650	0	4	_aCohort Studies
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aEurope _xepidemiology
650	0	4	_aFemale
650	0	4	_aFibrinolytic Agents _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aInjections, Intravenous
650	0	4	_aIntracranial Embolism _xdrug therapy
650	0	4	_aJapan _xepidemiology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNorth America _xepidemiology
650	0	4	_aProspective Studies
650	0	4	_aThrombolytic Therapy _xadverse effects
650	0	4	_aTime Factors
650	0	4	_aTissue Plasminogen Activator _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aMori, Etsuro
700	1		_aMinematsu, Kazuo
700	1		_aNakagawara, Jyoji
700	1		_aHashi, Kazuo
700	1		_aSaito, Isamu
700	1		_aShinohara, Yukito
773	0		_tStroke _gvol. 37 _gno. 7 _gp. 1810-5
856	4	0	_uhttps://doi.org/10.1161/01.STR.0000227191.01792.e3 _zAvailable from publisher's website
999			_c16358909 _d16358909